Relationship between obstructive sleep apnea and poorer outcomes from COVID-19 has been identified.
People with obstructive sleep apnea could be at a higher risk of adverse outcomes from COVID-19, revealed a new study from the University of Warwick. The findings of the study are published in Sleep Medicine Reviews. The review looked at 18 studies up to June 2020 about sleep apnea and COVID-19, 8 studies were related to death risk from COVID-19. and 10 were related diagnosis, treatment, and management of sleep apnea.
Diabetic patients hospitalized for coronavirus and being treated for sleep apnea were at 2.8 times greater risk of dying on the seventh day after hospital admission.
What is obstructive sleep apnea (OSA)
- Obstructive sleep apnea should be suspected in overweight middle-aged adults who snore loudly and which can cause interruption of breathing for 10 seconds or more and this results in reduced blood.
- In the UK, up to 85% of obstructive sleep apnea disorders are undetected, 1.5 million people in the UK currently diagnosed with the condition.
- Continuous positive airway pressure (CPAP) is the treatment option.
The review highlights that the pandemic has also had worldwide effects on patients with sleep conditions. Moving forward, it may be necessary to explore new diagnosis and treatment pathways for these individuals.
Tips for good night's sleep
- Reconsider aromatherapy
- Use the sofa
- Stop painkillers
- Take a hot bath
- Grab a book
- Take a magnesium supplement
Source-Medindia